Enhancement of muscle blood cell flux and pO2 by cromakalim (BRL 34915) and other compounds enhancing membrane K+ conductance, but not by Ca2+ antagonists or hydralazine, in an animal model of occlusive arterial disease.

Source:http://linkedlifedata.com/resource/pubmed/id/3393236

Download in:

View as

General Info

PMID
3393236